Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
ICU Medical, Inc. is a medical technology company focused on the development, manufacture, and sale of devices used in infusion therapy, vascular access, and critical care applications. The company operates within the medical devices and hospital consumables industries, serving acute care hospitals, outpatient facilities, and alternate care settings. Its core offerings are designed to improve patient safety by reducing the risk of infection and medication errors during intravenous (IV) therapy.
The company’s primary revenue drivers include single-use medical consumables and durable infusion delivery systems used in routine and high-acuity clinical environments. ICU Medical is recognized for its emphasis on needle-free and closed-system technologies, which provide a strategic advantage aligned with hospital safety protocols and regulatory standards. The company was founded in 1984 by George A. Lopez and initially focused on IV connectors; over time, it expanded organically and through acquisitions, most notably transforming its scale and portfolio following the acquisition of Smiths Medical in 2022.
Business Operations
ICU Medical generates revenue through the sale of disposable consumables and capital equipment supported by recurring demand from hospital systems. Its operations are broadly organized around Consumables and Infusion Systems, encompassing IV connectors, catheters, needle-free valves, infusion pumps, and related monitoring and delivery technologies. These products are integrated into hospital workflows, creating repeat purchasing behavior tied to patient volumes and long-term customer relationships.
The company conducts both domestic and international operations, with manufacturing, distribution, and sales functions spanning multiple regions. ICU Medical controls proprietary infusion and safety technologies and maintains a portfolio expanded through Smiths Medical, which operates as a wholly owned subsidiary. The company also engages in commercial partnerships with group purchasing organizations and healthcare providers, which play a significant role in market access and contract-based sales.
Strategic Position & Investments
ICU Medical’s strategic direction centers on expanding its global infusion therapy platform, optimizing its consumables-led revenue model, and integrating acquired assets to drive operational efficiency. A key growth initiative has been the acquisition and integration of Smiths Medical, which significantly broadened its infusion systems, vascular access, and critical care product offerings while increasing its global customer base.
The company continues to invest in product development aimed at enhancing safety, connectivity, and clinical efficiency, particularly in closed-system transfer devices and advanced infusion technologies. ICU Medical also focuses on operational improvements, including supply chain optimization and manufacturing scale, to support long-term margin performance and competitiveness in regulated healthcare markets.
Geographic Footprint
ICU Medical is headquartered in North America, with its corporate headquarters located in the United States. The company maintains a substantial presence across North America and Europe, supported by manufacturing facilities, distribution centers, and direct sales organizations. These regions represent the majority of its revenue base, driven by established hospital infrastructure and demand for safety-focused infusion technologies.
Beyond its core markets, ICU Medical has operational and commercial reach in Asia-Pacific, Latin America, and other international regions through subsidiaries and third-party distribution networks. The integration of Smiths Medical further expanded its international footprint, enhancing its influence in global hospital and critical care markets.
Leadership & Governance
ICU Medical’s leadership team emphasizes patient safety, product quality, and disciplined capital allocation as central elements of its strategic vision. The company is led by executives with experience in medical technology, healthcare operations, and large-scale manufacturing, reflecting its focus on regulated markets and global expansion.
Key executives include:
- Vivek Jain – President and Chief Executive Officer
- Brian Bonnell – Chief Financial Officer
- George A. Lopez – Founder and Former Chief Executive Officer